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http:WHAT THIS PAPER ADDS
A major proportion of large chronic tissue defects in the foot treated with free ﬂap transfer are of diabetic origin
with either neuro-ischaemic or predominantly neuropathic aetiology. Revascularisation in conjunction with free
ﬂap transfer may be necessary. This paper describes for the ﬁrst time, the strategies for free ﬂap transfer in both
neuro-ischaemic and predominantly neuropathic large diabetic foot defects, as well as the long-term outcome in
different treatment groups.Objective/Background: To analyse the impact of ischaemia and revascularisation strategies on the long-term
outcome of patients undergoing free ﬂap transfer (FFT) for large diabetic foot lesions penetrating to the tendon,
bone, or joint.
Methods: Foot lesions of 63 patients with diabetes (median age 56 years; 70% male) were covered with a FTT in
1991e2003. Three groups were formed and followed until 2009: patients with a native in line artery to the ulcer
area (n ¼ 19; group A), patients with correctable ischaemia requiring vascular bypass (n ¼ 32; group B), and
patients with uncorrectable ischaemia lacking a recipient vessel in the ulcer area (n ¼ 12; group C).
Results: The respective 1, 5, and 10 year amputation free survival rates were 90%, 79%, and 63% in group A; 66%,
25%, and 18% in group B; and 50%, 42%, and 17%, in group C. The respective 1, 5, and 10 year leg salvage rates
were 94%, 94%, and 87% in group A; 71%, 65%, and 65% in group B; and 50%, 50%, and 50% in group C. In 1 year,
43%, 45%, and 18% of the patients in groups A, B, and C, respectively, achieved stable epithelisation for at least 6
months. The overall amputation rate was associated with smoking (relative risk [RR] 3.09, 95% conﬁdence
interval [CI] 1.8e5.3), heel ulceration (RR 2.25, 95% CI 1.1e4.7), nephropathy (RR 2.24, 95% CI 1.04e4.82), and
an ulcer diameter of >10 cm (RR 2.08, 95% CI 1.03e4.48).
Conclusion: Despite diabetic comorbidities, complicated foot defects may be covered by means of an FFT with
excellent long-term amputation free survival, provided that a patent native artery feeds the ulcer area. Ischaemic
limbs may also be salvaged with combined FFT and vascular reconstruction in non-smokers and in the absence of
very extensive heel ulcers. Occasionally, amputation is avoidable with FFT, even without the possibility of direct
revascularisation.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The inﬂuence of chronic ischaemia on outcome after free
ﬂap transfer (FFT) in large diabetic foot lesions is a largely
un-investigated issue.1 In general, neuro-ischaemic diabetic
foot lesions fare much worse than the purely neuropathicof original article: http://dx.doi.org/10.1016/j.ejvs.2015.04.029
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//dx.doi.org/10.1016/j.ejvs.2015.04.004ones.2,3 In the absence of peripheral arterial disease (PAD),
the free ﬂap may be anastomosed to local vessels; however,
when the local arterial circulation is insufﬁcient, a
preliminary vascular bypass for inﬂow is necessary. Previous
series have mostly involved patients with combined FFT and
vascular bypass in mixed series with diabetic and non-
diabetic patients. Series including only patients with
diabetes are available but a comparison of outcomes in
patients with and without vascular reconstruction has not
been performed.1,4
Therefore, this study analysed the long-term outcome of
FFT in patients with diabetes with large chronic foot defects
in three patient groups. Group A had predominantly
neuropathic lesions with an in line native artery to the ulcer
224 M. Kallio et al.area; group B had lesions with critical ischaemia treated
with vascular bypass; and group C had lesions with uncor-
rectable critical ischaemia.
MATERIALS AND METHODS
Between 1991 and 2003, large tissue defects of the foot
were debrided and covered with FFT in 63 patients with
diabetes. According to the University of Texas wound clas-
siﬁcation system, 57 were 3AeD and six were 2AeD le-
sions.5 The ulcer diameter exceeded 10 cm in 44% of the
patients, whereas the smallest area was 5  3 cm. In most
patients, the ulcer extended to two or more angiosome
regions.6 The patients had undergone multiple revisions
and many unsuccessful attempts at covering the tissue
defect with skin grafting or local ﬂaps in the past. Without
proper wound excision and FFT, all patients would have
faced major amputation.
Free ﬂap surgery was considered if the tarsal bones and
the body of the calcaneus could be saved, taking into ac-
count the general condition of the patient. The ability to
walk or move a wheelchair independently had to be
retained, and life expectancy had to be reasonable. The
decision tree used is available in a previously published
article.7 A multidisciplinary team, consisting of a plastic
and a vascular surgeon, specialists in internal medicine and
in infectious diseases, and an anaesthesiologist, evaluated
each candidate for FFT. An infection unresponsive to an-
tibiotics and debridement, as well as a progressive
gangrene of the foot despite revisions after proper revas-
cularisation, were beyond the reach of even this kind of
treatment.
A stressful peri-operative period and recovery time
necessitated careful pre-operative evaluation of the general
condition and cooperation of the patient. Uraemia was
mostly considered as a contraindication. Two uraemic pa-
tients were operated on in 1995 and 1997. Suitability for
general anaesthesia, prolonged operation time, and major
bleeding were weighed carefully.Procedure
The ulcers were ﬁrst excised, along with all diseased bone,
creating a fresh wound bed. The free ﬂap was selected on
the basis of the size, depth, and location of the defect.
Furthermore, comorbidities related to ﬂap raising and po-
tential atherosclerosis in the ﬂap vessels were evaluated.
The 38 latissimus dorsi (LD), 11 rectus abdominis (RA), and
eight forearm ﬂaps (FA) were the most frequently used. LD
and RA ﬂaps were mainly covered with skin grafting,
whereas FA ﬂaps were fascio-cutaneous. The serratus
muscle was used twice, and the gracilis, adductor, vastus
lateralis, and parascapularis ﬂaps once each, using a surgical
technique described previously.8
With vascular reconstruction, an in line arterial supply to
the foot or ankle according to the ulcer location was created
whenever possible. Of the 48 concomitant vascular re-
constructions, 36 were performed simultaneously with the
FFT. In staged operations, the FFT was performed if theulcer showed no healing within 1e8 weeks, and in one case
1 year after the vascular reconstruction.
In vascular bypass operations, heparin was infused peri-
operatively before clamping the artery. In separate ﬂap
transfer operations with microvascular anastomosis only, no
intravenous heparin was given. Post-operatively, low mo-
lecular weight heparin was administered in the surgical unit.
Acetylsalicylic acid with daily dosage of 100 mg was intro-
duced permanently except in patients on warfarin.Design
The patients were divided retrospectively into three groups
according to the presence and severity of PAD, based on the
ﬁndings at angiography and at operation (Fig. 1). This divi-
sion was congruent with available non-invasive measure-
ments (Table 1). All patients, except ﬁve in group A,
underwent a conventional pre-operative angiogram or dig-
ital subtraction angiogram. In these ﬁve patients the
microvascular anastomosis was performed to a pedal vessel
with a palpable pulse.
In group A (n ¼ 19), a patent native arterial line supplied
the ulcer area. Patients were included in group A if the
anterior tibial (ATA) or the posterior tibial artery (PTA)
continued below malleolar level, supplying arterial circula-
tion to the ulcer area in the foot, or if the ATA, PTA, or
ﬁbular artery reached the malleolar level and fed the ulcer
area in the ankle and Achilles tendon region. These large
lesions covered several angiosomes, and the angiosome
concept as such could therefore not be used.
A local native artery served as the inﬂow vessel in 14 of
19 patients in group A. The remaining ﬁve patients had
patent but calciﬁed leg arteries, not suitable for micro-
vascular anastomosis, and an end to end anastomosis was
performed between an inﬂow conduit and the ﬂap artery.
The toe pressures in four of these ﬁve legs were 78, 64, 55
and 34 mmHg, respectively; in one patient, toe pressure
measurements were not available. In the latter two pa-
tients, however, an arterial line was patent down to the
foot on angiography. Three patients in group A underwent
a preceding percutaneous transluminal angioplasty of a
short stenosis in the superﬁcial femoral artery or crural
vessels. Their toe pressure values were between 56 and
69 mmHg before the angioplasties, which were performed
to achieve the best possible circulation prior to major
surgery.
Patients in group B (n ¼ 32) had correctable ischaemia.
All patients underwent bypass of an occluded arterial line to
an outﬂow vessel reaching the foot. The ﬂap inﬂow was
taken either end to side from the vascular graft (n ¼ 28) or
from a native outﬂow artery (n ¼ 4).
Twenty-one patients had a simultaneous FFT and vascular
reconstruction, whereas 11 had a staged operation. The
simultaneous operation was done when the tissue defect
already necessitated FFT pre-operatively. If the nearby tis-
sues or skin grafting were not sufﬁcient to cover the tissue
defect, the staged operation was performed after a vascular
reconstruction and subsequent revisions.
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Figure 1. Patients and vascular supply.
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ischaemia had an occluded arterial line without a distal
outﬂow vessel. Reconstitution of direct ﬂow to the ulcer
area was thus not possible. A more proximal bypass was
performed, if appropriate, with the ﬂap inﬂow from the
vascular graft (n ¼ 5). Otherwise, an end to end anasto-
mosis between the ﬂap artery and an inﬂow conduit from a
more proximal native artery was performed (n ¼ 6). One
patient with occluded pedal vessels had inﬂow from the
distal ATA at the ankle.Follow up and outcome measures
The follow up lasted until December 2009 or until patient
death. Amputation free survival (AFS), leg salvage, survival,
and ulcer healing time were assessed. The follow up data
were retrieved from patient records of the Helsinki Uni-
versity Hospital, local hospitals, and healthcare centres, as
well as home nursing records. Based on clinical experience
of frequent recurrent ulceration, an ulcer was considered
healed only if it remained epithelised for at least 6 months.
However, the day when full epithelisation was observed for
the ﬁrst time was considered the date of healing.
The ethics committee of Helsinki University Central
Hospital approved the study.Statistics
Median and interquartile range were the descriptive sta-
tistics used. Categorical data were compared between the
groups using the chi-square test or Fischer’s test in case ifany of the cells had an expected count of <5. The following
risk factors for amputation in a dichotomous form were
tested: sex, nephropathy (serum or plasma creatinine levels
exceeding laboratory reference values, renal transplantation
patients with increased creatinine, uraemia), type of dia-
betes, ever smoking, American Society for Anesthesiologists
(ASA) score (4 vs. ASA 2 or 3), previous major amputation,
type of ﬂap (LD or RA vs. other ﬂaps), ulcer properties
(location in the heel and the forefoot vs. other locations,
plantar involvement, greatest diameter >10 cm). Risk ratios
with 95% conﬁdence intervals (CIs) were calculated for
signiﬁcant risk factors in the chi-square test. The continuous
variables that were tested using the ManneWhitney U test
included body mass index, age, pre-operative C-reactive
protein (CRP), toe pressure, and ankle brachial index (ABI).
Survival was studied by means of KaplaneMeyer analysis.
The estimated median survival was given with a 95% CI.
Differences between groups were tested with the log rank
test. A p-value < .05 was considered statistically signiﬁcant.
SPSS 17.0 (IBM, Armonk, NY, USA) was used for the sta-
tistical analyses.
RESULTS
At baseline, a signiﬁcant difference between the groups was
observed in respect of CRP, number of earlier major am-
putations, creatinine, lesion location, pre-operative toe
pressure, and ABI (Table 1).
Altogether, seven patients underwent ipsilateral endo-
vascular treatment or vascular re-operation during the
follow up, two in the patent native artery group, four in the
Table 1. Patient characteristics.
All Native artery
(NA)
Correctable
ischaemia (C)
Uncorrectable
ischaemia (U)
p (NA vs. C) p (C vs. U) p (NA vs. U)
n 63 19 32 12
Median age, years (IQR) 56 (21) 55 (17) 63 (24) 56 (19) NS NS NS
Male 44 (70) 11 23 10 NS NS NS
Type 1 diabetes 24 (38) 8 12 4 NS NS NS
History of smoking 12 (19) 1 8 3 NS NS NS
ASA 4 14 (22) 2 8 4 NS NS NS
Elevated creatininea 13 (21) 1 6 6 NS .05 .01
Renal transplantationb 8 (13) 3 5 4 NS NS NS
Retinopathy 43 (81)c 14 21 8 NS NS NS
CAD 20 (32) 3 13 4 NS NS NS
History of MI 12 (19) 2 7 3 NS NS NS
CVD 7 (11) 1 4 2 NS NS NS
Median BMI (IQR) 24.5 (6.0) 24.5 (5.5) 25.0 (6.0) 23.0 (6.0) NS NS NS
History of BKA/AKA 14 (22) 1 11 2 .02 NS NS
Median pre-operative TP (IQR)d 35 (33) 60 (43)e 30 (21)f 34 (45)g .001 NS .01
Median pre-operative ABI (IQR)h .99 (.78) 1.19 (.42)i .71 (.84)j .86 (.98)k .01 NS NS
Lesion in the ankle 7 (11) 5 2 0 NS NS NS
Lesion in the forefoot 30 (48) 7 14 9 NS NS .04
Lesion in the heel 18 (29) 4 13 1 NS .04 NS
Plantar involvement 44 (70) 11 24 9 NS NS NS
Heel lesion > 10 cm 10 (16) 2 8 0 NS NS NS
Ulcer diameter > 10 cm 28 (44) 9 13 6 NS NS NS
Pre-operative infection 41 (65) 14 21 6 NS NS NS
Median pre-operative CRP (IQR) 38 (46) 28 (5e38) 48 (53)l 37.5 (63.5) .002 NS NS
Bypass to ﬂap 11 (17) 5 6
Pedal bypass 23 (37) 23
Crural bypass 13 (21) 8 5
Popliteal bypass 1 (2) 1
PTA 3 (5) 3
LD ﬂap 38 (60) 12 20 6 NS NS NS
Median ﬂap OT, min (IQR) 276 (53)m,n 280 (48)o 323 (60)p
Median vascular OT, min (IQR) 177 (61)q 197r
Median combined OT, min (IQR) 354 (154)s 387 (80)t 356 (104)u
Note. Data are given as n (%) unless otherwise indicated.
IQR ¼ interquartile range; ASA ¼ American Society of Anesthesiologists; CAD ¼ coronary artery disease; MI ¼ myocardial infarction;
CVD ¼ cerebrovascular disease; BMI ¼ body mass index; BKA ¼ below knee amputation; AKA ¼ above knee amputation; TP ¼ toe
pressure; ABI ¼ ankle brachial index; CRP¼ C-reactive protein; PTA ¼ percutaneous transluminal angioplasty; LD ¼ latissimus dorsi;
OT ¼ operation time; NS ¼ not signiﬁcant.
a Two patients were uraemic.
b Normal serum creatinine, four of 12 of patients with renal transplant had elevated creatinine.
c n ¼ 53.
d n ¼ 41.
e n ¼ 11.
f n ¼ 23.
g n ¼ 7.
h n ¼ 50.
i n ¼ 13.
j n ¼ 26.
k n ¼ 11.
l n ¼ 31.
m Including PTA.
n n ¼ 14.
o n ¼ 11.
p n ¼ 2.
q n ¼ 11.
r n ¼ 1.
s n ¼ 5.
t n ¼ 21.
u n ¼ 10.
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ischaemia group.Survival
The overall 30 day mortality was 3% (two patients). The
survival rate at 1 year was 95% in group A, 94% in group B,
and 92% in group C. The respective 5 year survival rates in
groups A, B, and C were 84%, 47%, and 67%; the respective
10 year survival rates were 67%, 27%, and 21%. Estimated
median survival in group A was 149 months (95% CI 90e
208), in group B 54 months (95% CI 17e91), and in group C
76 months (95% CI 52e100). Survival was signiﬁcantly
better in group A compared with groups B (p ¼ .001 and C
(p ¼ .03)Leg salvage and AFS
The overall 30 day amputation rate was 11% (seven pa-
tients). During follow up, a total of 19 (30%) legs underwent
major amputation: two (11%) in group A, 11 (58%) in group
B, and six (32%) in group C. The reasons for amputation
were ﬂap failure (n ¼ 7), persisting infection (n ¼ 4), a
thrombosed vascular graft (n ¼ 4), persistent ulceration
(n ¼ 2), and new ulceration (n ¼ 2).
The estimated mean leg salvage time in group A (187
months; 95% CI 161e213) was signiﬁcantly longer than in
groups B (93 months; 95% CI 70e117) and 3 (75 months; CI
34e116) (Fig. 2). After 1 year, only three major amputations
were performed (at 14, 18, and 90 months, respectively).
The ﬁnal amputation level was above the knee in threeFigure 2. Leg salvage. Differences between groups A and B, as well A a
rank test.patients; 10 patients ended up having bilateral below or
above knee amputation.
The median AFS time was signiﬁcantly longer in group A
(149 months; 95% CI 92e206) compared with groups B (27
months; 95% CI 18e36) and C (11 months; 95% CI 0e53)
(Fig. 3).
Of the 41 patients retaining the leg with a ﬂap at 12
months, 16 walked without restriction, 20 had restriction in
distance or used a cane or walker, three were able to take
some steps, and two were ambulating by wheelchair.Risk factors for amputation
For the entire series, the risk of amputation was increased
in smokers (relative risk [RR] 3.09, 95% CI 1.8e5.3;
p ¼ .004) (Fig. 4), patients with a heel ulcer (RR 2.25, 95% CI
1.1e4.7; p ¼ .013), patients with nephropathy (RR 2.24,
95% CI 1.04e4.82; p ¼ .048) and patients with an ulcer
diameter >10 cm (RR 2.08, 95% CI 1.03e4.48; p ¼ .058). In
group B, the risk was increased in smokers (RR 5.7, 95% CI
1.7e19.9; p ¼ .010) and in patients with an ulcer
diameter > 10 cm (RR 2.9, 95% CI 1.27e6.64; p ¼ .021). An
increased risk with ulcer location in the heel (RR 1.9, 95% CI
.97e3.7; p ¼ .072) or nephropathy (RR 3.8, 95% CI .9e
16.18; p ¼ .148) was not shown in group B. In groups A and
C, risk factors were not identiﬁed.Ulcer healing
In group A, 84% (16/19) of the ulcers healed (and remained
epithelised for at least 6 months) in a mean time of 19nd C, were signiﬁcant (p ¼ .04 and p ¼ .006) by KaplaneMeier log
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Figure 3. Amputation free survival. The difference between groups A and each of B and C were signiﬁcant (p < .001 and p ¼ .01) by
KaplaneMeier log rank test.
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Figure 4. Leg salvage in smokers and non-smokers in the whole series. p ¼ .001 by KaplaneMeier log rank test.
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months (95% CI 6e13); and in group C, 33% (4/12) healed
in 20 months (95% CI 6e35). The proportion of healed ul-
cers was greater in group A than in groups B (p ¼ .041) and
3 (p ¼ .007), whereas between groups B and C, the dif-
ference did not reach signiﬁcance (p ¼ .061). There were no
signiﬁcant differences in healing times between the groups.
Three legs (one in group A and two in group C) avoided
amputation despite ﬂap loss. Two healed after skin grafting
in 5 and 13 months, respectively, and one after re-
amputation at proximal metatarsal level after 6 months.
These patients were included in the KaplaneMeier analysis.DISCUSSION
In a diabetic foot with a remarkable tissue defect, FFT may
offer the last chance to avoid amputation. A selection of
different strategies is necessary when treating these ulcers
with FFT as the presence and pattern of atherosclerosis
varies. A multidisciplinary decision to proceed to these
major reconstructions was made after careful pre-operative
evaluation.7 It was found that the outcome of FFT in terms
of leg salvage is highly associated with the severity of PAD
and the possibility of revascularising the leg. The overall
amputation rate in patients with a patent native artery was
10% versus the 30% in patients with correctable ischaemia
and 50% in patients with uncorrectable lower leg ischaemia.
Of note, by excluding smokers, the leg salvage rate in pa-
tients with a patent native artery corresponds roughly with
the rate in patients with correctable ischaemia. Indeed,
smoking and large ulcers, especially in the heel, as well as
nephropathy are the most notable predictors of failure.
However, the risk factor proﬁle is a complex issue (other
signiﬁcant predictors of poor outcome cannot be stated) as
half of the patients in the most unfortunate uncorrectable
ischaemia group avoided major amputation.
Amputations mostly occurred in the ﬁrst post-operative
year, whereas mortality continued on a linear course in all
groups during the follow up. The durability of leg salvage
after 2 years was surprisingly good, considering the pro-
gressive nature of ischaemic disease. This may, in part, be
attributable to the high early mortality of the most morbid
patients. Recent severe foot problems probably also
increased the watchfulness among the patients and their
caregivers.
Patients with a patent artery, not needing a revascular-
isation, had a long survival and good probability of leg
salvage. A remarkable number of patients with signiﬁcant
ischaemia had an AFS of many years. Surprisingly, revas-
cularisation, mostly to the pedal vessels, did not seem to
improve leg salvage signiﬁcantly compared with patients
with uncorrectable ischaemia. One explanation might be
the more extensive tissue lesions in the correctable
ischaemia group compared with the group with uncorrect-
able ischaemia.
It is likely that some patients with complicated defects
but no recipient vessel were not considered to beneﬁt from
FFT and the procedure was never offered to them.However, despite the anastomosis to a pedal vessel and the
satisfactory post-operative toe pressure values, it is still
possible that the most distal vessels were diseased. In all,
the low number of patients in group C prevents deﬁnitive
conclusions.
The similar mortality, signiﬁcantly higher than in the
native artery group, in the groups with correctable and
uncorrectable ischaemia, reﬂects the increased risk of car-
diovascular mortality in these patients with severe periph-
eral arterial disease. Remarkably however, despite the high
mortality in patients with atherosclerosis, a beneﬁt from
such a major surgery can be achieved.
Ulcer size as a risk factor for limb loss is argued to make
these procedures meaningless. This is a misconception, as
only large and complicated lesions were considered for this
kind of treatment. Indeed, not only the size but also the
extent and location of the lesion may be problematic. The
issue with size can be summarised in the question of
whether the extensive lesions leaving very little of the foot
untouched and extending over more than one angiosome
could also have a capacity to heal with this kind of
treatment.
Only two patients with uraemia, operated on in 1995 and
1997, were included in this cohort. Later, patients with
uraemia were not treated with FFT, based on clinical
experience and published reports. Paradoxically, both pa-
tients with uraemia retained their legs. However, in line
with previous studies, high creatinine levels were associated
with amputation.4
Ulcer healing has rarely been reported in connection with
FFT and diabetic or ischaemic ulcers.7 Based, on the clinical
experience of the authors, recurrent ulceration is frequent
after FFT. Therefore, in this study, healing was deﬁned as full
epithelisation for a minimum of 6 months. In almost half of
the patients, ulcers healed in 6 months, but in the other
half, the healing took longer (up to 81 months).
Previously, FFT has mainly been studied in combination
with vascular reconstruction in patients with or without
diabetes.4,7,9 In two large series, which combined FFT and
revascularisation, the proportions of patients with diabetes
were 71% and 76%, respectively.4,9 In those series, the 5
year limb salvage rates were 63% and 71%, respectively,
similar to the data obtained in the present study; however,
in this study, long-term mortality was higher, probably
indicating a more morbid group of patients. Only a few
cases of FFTs with an inﬂow from a proximal vessel directly
to the ﬂap in the absence of a recipient vessel in the foot,
also called nutrient ﬂaps, have been described previ-
ously.4,10e12 Twelve such patients were included in the
present study, six of whom reached at least 2 years of AFS.
Patients with no need for vascular reconstruction have been
included in earlier series of patients with diabetes, but their
outcome has not been analysed separately.4,13e15
Angiographic ﬁndings were the main methods used to
distinguish the extent of occlusive arterial lesions in the
present study. Pre-operative angiography is a valuable
method for predicting outcome after femoro-crural bypass
surgery.16 For 16 patients ABI and toe pressure values were
230 M. Kallio et al.not available owing to foot level amputations, medial
sclerosis, and challenging logistics related to many diag-
nostic procedures, urgent operations, and transfers from
other hospitals. TcpO2 measurement, which was re-
established successfully in recent years after a long pause
due to reliability issues, might have been of assistance.
Novel methods popularised over the last 15 years, such
as crural and pedal PTA and negative pressure wound
therapy, especially in the most severe cases, can serve as an
adjuvant to FFT, ideally with an improved outcome for the
patient.17
CONCLUSION
Even in diabetic patients with signiﬁcant comorbidities and
complicated large leg ulcers, excellent long-term AFS may
be expected with free ﬂap coverage in the presence of a
patent native artery. Ischaemic limbs in patients with dia-
betes may also often be salvaged with a combination of a
free ﬂap and vascular reconstruction. Diseased run-off
vessels not allowing proper revascularisation should lead
to a meticulous weighing of the risks and beneﬁts of the
operation; however, half of these procedures were suc-
cessful in the present series. Smoking and a large ischaemic
ulcer in the heel are predictors for unfavorable outcome. In
the most diseased patients, amputation should be consid-
ered in order to avoid unnecessary major surgery and
rehabilitation.
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